Requests that the FDA: Publicly disavow and condemn that certain medical journal article "Efficacy of Paroxetine in the Treatment of Adolescent Major Depression: A Randomized, Controlled Trial," Keller, JAACAP, July 2001 (herein after the Keller article attached as Exhibit 1) as scientifically invalid and dangerous to public health | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2025-P-3263

Requests that the FDA: Publicly disavow and condemn that certain medical journal article "Efficacy of Paroxetine in the Treatment of Adolescent Major Depression: A Randomized, Controlled Trial," Keller, JAACAP, July 2001 (herein after the Keller article attached as Exhibit 1) as scientifically invalid and dangerous to public health

Documents

Comments

Description

CLOSED

Key Dates

Comment Period OpensAug 20, 2025

Documents

Type	Title	Posted	Comments	Status
Other	Final Response Letter from FDA CDER to George W. Murgatroyd III	Apr 17, 2026	--

Keywords

CDER

Citizen Petition

Requests that the FDA: 1. Publicly disavow and

condemn that certain medical journal article

"Efficacy of Paroxetine in the Treatment of

Adolescent Major Depression: A Randomized,

Controlled Trial," Keller, JAACAP, July 2001

(herein after the Keller article attached as

Data from Regulations.gov